Abstract
COVID-19 is an emerging infectious disease, first reported in Wuhan, China. The deadly disease currently known as SARS-CoV-2 can affect everyone regardless of race, gender or age. However, people suffering from underlying medical conditions such as hypertension, diabetes, and other chronic diseases are at the biggest risk for developing more intense symptoms and complications. The global challenge in the containment of COVID-19 has led to a massive death rate and resulted in many economic, social, and health burdens around the world, leading to the question of the dynamic of COVID-19 management treatment. Therefore, this paper aimed to systematically review different past and present studies to develop a possible solution on how COVID-19 can be managed and treated. The articles were searched from five online databases: Science Direct, PubMed/Medline, Web of Science, Embase, and Scopus. The systematic review was guided by the guidelines presented in the preferred reporting items for systematic reviews and meta-analyses (PRISMA) from 2019–2021. Thirteen articles were included after reviewing seventy-two articles. Three hypotheses guided the study; clinical management, telehealth technology, and performance intelligence as an effective way of managing and controlling COVID-19. The study concludes there is no proven treatment for the virus yet, but clinical treatment, telehealth technology, and performance intelligence can effectively manage and control the virus. It also recommends policymakers should support the development and the implementation of performance intelligence based on the evidence and standardized data available for effective and pandemic resilience health care systems that will address the control and management of the virus.
 Keywords: SARS2, SARS-CoV-2, Novel Coronavirus, 2019nCoV, COVID-19.
Highlights
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is the causative agent of a potentially deadly illness that is a significant public health issue worldwide (Rothan et al, 2020)
Published journals and reports on the experience of clinical treatment of the virus and other clinical trials not mentioned in this paper are primarily descriptive reports and case series from countries that are heavily hit by the virus
This study argues in favor of telehealth services and against traditional approaches used in diagnosing COVID-19
Summary
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is the causative agent of a potentially deadly illness that is a significant public health issue worldwide (Rothan et al, 2020). The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected millions worldwide due to its high incidence and lengthy incubation times, which are without symptoms (Chung et al, 2021). On April 25th, 2021, WHO confirmed 151,803,822 cases and 3,186,538 death reports worldwide. People with chronic conditions such as hypertension, cardiovascular disease, diabetes mellitus, chronic obstructive pulmonary disease are at high risk of getting COVID-19. Neither a vaccine nor a specific antiviral drug is available to treat critically ill patients. The management of patients mainly focuses on providing supportive care, e.g., oxygenation, ventilation, and fluid management (Cunningham et al, 2020)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
